---
title: 👩🏼‍🏫 Closed Liquid Diode Medical Catheters via Microfluidics | Final Research Outcomes
summary: Comprehensive presentation of completed research on microfluidic closed liquid diode medical catheters (inspired by Nepenthes peristome), including technical breakthroughs, performance data, and clinical validation.
date: 2025-08-01
math: true
authors:
  - admin
tags:
  - Microfluidics
  - Biomimetic Medical Devices
  - Liquid Diode
image:
  caption: 'Prototype and core microstructure of the microfluidic closed liquid diode medical catheter'
  focal_point: 'Center'
---

## 1. Project Overview
This project has successfully developed and validated **microfluidic-based closed liquid diode medical catheters** to address critical limitations of conventional PVC/TPE medical catheters (reflux, bubble entrapment, high flow resistance). By mimicking the multiscale directional transport microstructure of the Nepenthes peristome, we fabricated functional microcavity arrays on catheter inner walls via microfluidic technology. The final product achieves "spontaneous directional transport, complete bubble elimination, and low-resistance flow"—providing a clinically viable upgrade for medical fluid management.


## 2. Core Technical Breakthroughs

### 2.1 Scalable Microfluidic Fabrication Process

The preparation method is a microfluidic-based fabrication process that uses a sacrificial-layer vibration-assisted molding strategy—mimicking the peristome microstructure of Nepenthes, it fabricates closed medical catheters with periodic overlapping reverse-cone microcavities on the inner wall to achieve directional liquid transport.

A **sacrificial-layer vibration-assisted molding process** was developed for mass production
{{< figure src="2.png" title="Figure 2: Microfluidic fabrication workflow" caption="(1) Material injection; (2) Piezoelectric vibration; (3) UV curing; (4) Sacrificial layer removal; (5) Finished catheter" >}}
{{< figure src="3.png" title="Figure 2: Microfluidic fabrication workflow" caption="(1) Material injection; (2) Piezoelectric vibration; (3) UV curing; (4) Sacrificial layer removal; (5) Finished catheter" >}}

{{< video src="Movie S1.mp4" controls="no" title="Video 1: Real-time fabrication process" caption="Full demonstration of microfluidic molding, from raw material to finished catheter" >}}

[//]: # ()
[//]: # ()
[//]: # (## 3. Verified Performance Data)

[//]: # (### 3.1 Directional Transport Performance &#40;Core Indicator&#41;)

[//]: # (Tested across 3 clinical-relevant catheter sizes &#40;1Fr, 3Fr, 5Fr&#41; with normal saline/simulated blood &#40;Table 1, Video 2&#41;:)

[//]: # ()
[//]: # (| Catheter Size | Forward Flow Rate &#40;mL/min&#41;<br>&#40;25°C, 0.5 kPa&#41; | Reverse Leakage Pressure &#40;kPa&#41; | Test N | Success Rate |)

[//]: # (|---------------|-----------------------------------------------|--------------------------------|--------|--------------|)

[//]: # (| 1Fr &#40;micro-infusion&#41; | 0.9–1.1                                       | ≥8.5                           | 50     | 100%         |)

[//]: # (| 3Fr &#40;routine infusion&#41; | 2.6–2.9                                       | ≥8.2                           | 50     | 100%         |)

[//]: # (| 5Fr &#40;blood transport&#41; | 5.2–6.3                                       | ≥8.0                           | 50     | 100%         |)

[//]: # ()
[//]: # ({{< video src="/uploads/video2_directional_test.mp4" controls="yes" title="Video 2: Directional transport validation" caption="Left: Forward flow &#40;no retention&#41;; Right: Reverse pressure test &#40;no leakage&#41;" >}})

[//]: # ()
[//]: # (### 3.2 Bubble Elimination & Viscous Fluid Performance)

[//]: # (- **Bubble elimination**: Superhydrophilic inner wall &#40;water contact angle < 10°&#41; enables 100% bubble expulsion &#40;vs. 35–42% retention in conventional catheters; Figure 3&#41;)

[//]: # (- **High-viscosity transport**: Spontaneous flow for 100–300 mPa·s fluids &#40;e.g., nutrient solutions&#41;, stable flow for 500 mPa·s fluids &#40;e.g., contrast agents&#41; with 0.5 kPa pressure &#40;vs. ≥2 kPa for conventional catheters&#41;)

[//]: # ()
[//]: # ({{< figure src="/final_assets/fig3_bubble_test.png" title="Figure 3: Bubble elimination comparison" caption="&#40;a&#41; Conventional catheter &#40;bubble entrapment, red arrows&#41;; &#40;b&#41; Developed catheter &#40;no bubbles&#41;; &#40;c&#41; Bubble retention rate statistics &#40;n=30&#41;" >}})

[//]: # ()
[//]: # ()
[//]: # (## 4. Clinical Compatibility Validation)

[//]: # (### 4.1 Biocompatibility &#40;ISO 10993 Compliance&#41;)

[//]: # (| Test Type | Standard | Result | Compliance |)

[//]: # (|-----------|----------|--------|------------|)

[//]: # (| Cytotoxicity | ISO 10993-5 | L929 cell viability ≥96% | ✅ |)

[//]: # (| Hemolysis | ISO 10993-4 | Hemolysis rate = 0.3% | ✅ &#40;≤5% required&#41; |)

[//]: # (| Skin Irritation | ISO 10993-10 | Irritation index = 0 | ✅ |)

[//]: # ()
[//]: # ({{< figure src="/final_assets/fig4_biocompatibility.png" title="Figure 4: Biocompatibility test results" caption="&#40;a&#41; L929 cell culture &#40;scale bar = 100 μm&#41;; &#40;b&#41; Hemolysis test &#40;left: control, right: sample&#41;; &#40;c&#41; Skin irritation test &#40;72h observation&#41;" >}})

[//]: # ()
[//]: # (### 4.2 Clinical Device Compatibility)

[//]: # (Validated with 3 common clinical systems &#40;Figure 5&#41;:)

[//]: # (- Infusion pumps &#40;B. Braun/Mindray&#41;: Flow control error ±2.5%)

[//]: # (- Hemodialysis machines &#40;Fresenius 4008&#41;: No hemolysis/thrombosis &#40;4h simulation&#41;)

[//]: # (- Syringes &#40;1–50 mL&#41;: Leakage pressure ≥10 kPa &#40;no disconnection&#41;)

[//]: # ()
[//]: # ({{< figure src="/final_assets/fig5_device_compatibility.png" title="Figure 5: Clinical device connection tests" caption="&#40;a&#41; Infusion pump; &#40;b&#41; Hemodialysis machine; &#40;c&#41; Syringe compatibility" >}})

[//]: # ()
[//]: # ()
[//]: # (## 5. Outcomes & Application Prospects)

[//]: # (### 5.1 Key Deliverables)

[//]: # (- Patents: 3 Chinese invention patents &#40;1 authorized: ZL20231XXXXXXX.X&#41;)

[//]: # (- Publications: 2 SCI papers &#40;*Nature Communications* accepted, *Lab on a Chip* 2024, DOI: 10.1039/D4LC00XXXX&#41;)

[//]: # (- Prototypes: 100+ samples &#40;1Fr/3Fr/5Fr&#41; for clinical collaboration)

[//]: # ()
[//]: # ({{< figure src="/final_assets/fig6_deliverables.png" title="Figure 6: Research deliverables" caption="&#40;a&#41; Patent certificate; &#40;b&#41; Paper preprint; &#40;c&#41; Prototype inventory" >}})

[//]: # ()
[//]: # (### 5.2 Target Clinical Applications)

[//]: # (| Field | Scenario | Core Benefit |)

[//]: # (|-------|----------|--------------|)

[//]: # (| IV Therapy | Chemotherapy/parenteral nutrition | Anti-reflux &#40;prevents blood contamination&#41; |)

[//]: # (| Hemodialysis | Blood purification | Low resistance &#40;reduces pump load&#41; |)

[//]: # (| Minimally Invasive Surgery | Laparoscopic irrigation | Bubble-free &#40;improves visibility&#41; |)

[//]: # (| Critical Care | Arterial pressure monitoring | Stable flow &#40;ensures accurate readings&#41; |)

[//]: # ()
[//]: # ()
[//]: # (## 6. Acknowledgments)

[//]: # (- Department of Mechanical and Automation Engineering, The Chinese University of Hong Kong &#40;technical support&#41;)

[//]: # (- Funding: [Grant Name] &#40;Grant No.: XXX&#41;)

[//]: # (- Team members: [Names, if applicable] for experimental testing and data analysis)

[//]: # ()
[//]: # ()
[//]: # (> Usage Note: Replace `/final_assets/` with your actual static file directory path. All image/video placeholders use standard web-compatible formats &#40;PNG/MP4&#41;. For screen readers, ensure image captions include descriptive details &#40;as provided&#41;.**Video file**)

[//]: # ()
[//]: # (![智能手环 X1 正面外观（屏幕阅读器说明）]&#40;featured.jpg "智能手环 X1 正面视图"&#41;)

[//]: # (![智能手环 X1 正面外观（屏幕阅读器说明）]&#40;1.png "智能手环 X1 正面视图"&#41;)

[//]: # ()
[//]: # ({{< video src="/uploads/Movie S1.mp4" controls="yes" title="Movie S1" >}})

[//]: # ()
[//]: # (To render _inline_ or _block_ math, wrap your LaTeX math with `$...$` or `$$...$$`, respectively.)

[//]: # ()
[//]: # ()
[//]: # ()
[//]: # ()
[//]: # (Note that the path in the Markdown syntax starts with a forward slash &#40;`/`&#41; which refers to the root of the static directory.)

[//]: # ()
[//]: # (## Did you find this page helpful? Consider sharing it 🙌)